Introduction
Methylphenidate (MPH), a substance that has been widely disseminated under its commercial name Ritalin ® , 1,2 is currently one of the world's top-selling central nervous system stimulants. 1 In the last two decades, there has been an enormous increase in its production and consumption. [1] [2] [3] This growth is explained by an increase in the diagnosis and treatment of attention deficit and hyperactivity disorder (ADHD) and also by the non-medical use (NMU) of MPH. 1, 4, 5 According to the U.S. National Survey on Drug Use and Health, the NMU of substances is defined as "the use of prescription-type psychotherapeutic drugs not prescribed for the respondent by a physician or used only for the experience or the feeling they caused." 1 For convenience, the term NMU will be used in this work only to refer to individuals that use MPH without a medical prescription for the treatment of a given neuropsychiatric disorder.
The use of MPH for the treatment of ADHD is sustained in several studies that have demonstrated its effectiveness and efficiency. [1] [2] [3] [4] Under the recommended dosage, it is considered a safe medication with a satisfactory level of side effects. When properly indicated, the chances of the drug leading to addiction are very low, and its use has actually been considered as a shield against the development of addiction in individuals with ADHD. 1 Therefore, for the treatment of ADHD, MPH represents the gold standard treatment; that use of MPH is not within the scope of this paper.
From a different standpoint, there has been recent concern as to the NMU of MPH. Such use appears to be becoming popular mainly among college students. 4, 6 Several studies show that MPH has been used nonmedically especially for hedonistic purposes (e.g., to "get high") [7] [8] [9] and in the expectation of cognitive enhancement by healthy individuals. 5, 10 The NMU of MPH seems to have grown in proportion to the number of prescriptions for the treatment of disorders such as ADHD; in some groups, the NMU of MPH seems to be actually greater than the use with therapeutic purposes. 9, 11 Therefore, there is a call for further study and discussion of the topic.
The use of MPH for cognitive enhancement came to prominence in the scientific field and popular media mainly after a 2008 article published online in the journal Nature, entitled "Poll results: look who's doping." The paper showed results of a poll carried out amongst readers of the journal all over the world.
One in every five of the 1,400 participants admitted to use stimulants to improve work performance. 12 Among those who used such substances, MPH was the drug of choice, accounting for 62% of the total. Evidence has suggested that MPH improves executive functions and memory in healthy individuals 13 ; some authors advocate its use, legalization and even the encouragement of such use. 12, 14, 15 However, the use of MPH for cognitive enhancement is controversial, because neither drug efficacy nor the benefit-risk balance provide sufficient evidence for this use. 16, 17 Moreover, MPH has some abuse potential, especially when used at an inappropriate dosage. 8, 18 In this regard, the use of MPH for hedonistic purposes is regularly done via inhalation and simultaneously with other substances. 1, 19 Also, the route of administration, drugs used in combination with MPH, and MPH dosage alter the safety profile of the medication. Thus, MPH use is associated with dangers such as addiction and severe side effects such as convulsions and hallucinations. 1, 6, 20 The addictive potential of MPH may be due to some effects of MPH in the brain that are similar to those of cocaine. 20 MPH inhibits the dopamine carrier, which increases synaptic levels of the neurotransmitter dopamine; this process is presumed to mediate the reinforcing effects and abuse potential of MPH. The difference between the two substances lies essentially on the fact that MPH has a different pharmacokinetics:
MPH clears from the brain at a significantly slower rate than cocaine, which seems to explain the relatively low potential of MPH abuse when used medically. 1, [20] [21] [22] However, when inhaled, the speed at which the drug is delivered to the brain changes, and the risks of abuse are possibly greater.
Several studies suggest that the NMU of MPH is associated with higher rates of the use of other substances among students, such as heavy episodic drinking. 9 Non-medical users of prescription stimulants were over six times more likely to report high-risk alcohol behavior. 11 Particularly, MPH seems to be used simultaneously with alcohol to produce euphoric effects and reduce the negative sensations of drunkenness. 23 It is known that using more than one drug at the same time can produce a synergistic effect beyond the additive effect of each drug. 1, 11 The simultaneous use of MPH and alcohol results in the production of a metabolite called ethylphenidate, of unknown toxicity. 23 Because the use of both MPH and alcohol is high, and co-administration of both substances is known to be prevalent, this topic deserves further investigation.
The NMU of MPH has originated several studies, mostly carried out in the U.S., the world's biggest 
Sample and sampling procedure
All medical students enrolled in the 5th and 6th year were contacted and invited to take part in the study.
Target participants were approached directly at university facilities (i.e., outpatient clinics, classrooms) by the research staff; they were than invited to participate and informed of research goals and data collection procedures. Of the 156 students enrolled, 152 were contacted, and all agreed to participate in the study.
Participants were asked to complete self-report questionnaires and to subsequently deposit them in a locked box. In order to encourage respondent reliability and anonymity, participants were assured that the box would remain closed until completion of the data collection phase.
Instruments
Based on literature findings, where admission is more difficult, has been pointed out as a risk factor in some studies. 24 Among the main motivations for the NMU of MPH it is possible to mention increased concentration, use as an aid to studying, and use to "get high." Thus, it is already well-documented that the non-therapeutic use of MPH is prevalent among college students, in several countries already studied.
In Brazil, as also in the U.S., there has been a 
Study design
The dataset of the current study derived from a multiple-session cross-sectional survey carried out over a 1-month period at a medical undergraduate course of a university in southern Brazil. 
Associations between MPH use and alcohol intake
Among non-medical users of MPH, 6 (17.14%) reported to have used MPH simultaneously with other drugs; among these, 5 (14.2%) reported having used it simultaneously with alcohol. The results showed that both overall use of MPH (i.e., regardless of prescription) and NMU of MPH were associated with AUDIT scores ≥ 8, which means potentially hazardous alcohol intake. Table   3 details MPH use and AUDIT scores. The motivations for NMU of MPH were also similar to those previously described in literature. The main motivations found in this work for NMU of MPH were to help in the studies, mentioned by 68%, and increased concentration, referred by 31.42%. The use of MPH with hedonistic purposes (e.g., taking the medication to go to parties) was informed by 5.71% of the population, and its use simultaneously with alcohol was reported by 14.28%. All these findings were similar to previous reports; for instance, in the study with psychology students, the simultaneous use of MPH and alcohol was reported by 19.3% of the sample. 33 In addition to the simultaneous use of MPH and alcohol, the study found a significant correlation (p = 0.029) between NMU of MPH and alcohol consumption at levels representing risk to health. This finding is in accordance with previous studies that concluded that non-medical users of MPH were significantly more likely to engage in alcohol abuse and report adverse alcohol consequences. 11 Conversely, another reason for concern about NMU of MPH described in the literature, namely, the inhaled use of MPH, suggested as prevalent in a review on the topic, 1 was not found in our sample.
Attitudes towards the use of MPH
Another significant correlation found in the present study was between NMU of MPH and the year that participants were attending. The number of 6th year students who had used MPH was more than twice higher than that of their 5th year counterparts (p = 0.004). Among the 6th year participants, 46.05% used MPH. This increased use in the last year of university is mostly non-medical and could be due to the approaching selection exams for medical residencies. Thereby the increased use of MPH would be motivated by a search for enhanced performance.
Concerning attitudes towards the use of a medication for cognitive enhancement, the study results were as follows: 88.8% agreed on the use of MPH by individuals with correlated neuropsychiatric disorder; 44.7% agreed on its use by healthy individuals; and 67.1% said that they would use it themselves. These findings are quite similar to those of an informal survey including 1,400 readers of the journal Nature. The percentage found in that survey for these three questions was, respectively, 96, 45, and 69%. 12 Additionally, 20.4% of the participants of the present study reported that, if they were doctors, they would prescribe controlled medication with small side effects to healthy individuals to help improve their cognitive performance.
The present findings should be analyzed in the context of some methodological limitations. Given the nature of the study, the small sample size is an important issue. Therefore, interpretation of the findings should consider psychosocial, economic, and biological plausibility aspects, and definite conclusions should only be drawn after independent replications.
Among the study participants, 26 (17.1%) said that they would feel pressured if they knew that colleagues were taking cognitive enhancers to prepare for qualifying tests.
Discussion
The present study concluded that 23.02% of our sample of 152 participants had made NMU of MPH. This finding is in accordance with previous research:
in a sample of 283 students attending an art school, a prevalence of 16% was found, 32 while in another study involving 150 psychology students, the prevalence was 31.3%. 33 A review carried out on the subject among college students found that rates ranged from 1.5 to 31%, with higher prevalence rates being reported by studies with convenience samples, in which populations with a higher risk of NMU of MPH were studied. 1 According to that review, a major risk factor for NMU of MPH is studying in a highly competitive environment, with people with greater purchasing power.
The vast majority of non-medical users of MPH in our sample (85.71%) began use in college. These results are also in accordance with what is described in the literature.
For example, in a study involving 3,500 students of a public university in the U.S., 79% of those who had made NMU of MPH had begun using it during college. 7 Added to this is the fact that, when comparing people of the same age who are vs. those who are not in college, the NMU of prescription stimulants among college students is more prevalent. 1 These findings support the idea that being a college student is a risk factor for NMU of MPH.
Another finding of this study that confirms previous data is that a majority of 71.4% acquired the medication free from friends. A study involving 9,161 students of a university in the U.S. found that 68% had obtained the medication for free from their colleagues. 34 This corroborates the idea that having a classmate using MPH with medical prescription increases the risk of NMU of the substance, and also that NMU of MPH increases in proportion to the indication of the drug for the treatment of disorders. Moreover, the results demonstrated that NMU of MPH is more prevalent than its use with therapeutic purposes, as some authors had already suggested. 
